Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMincon Grp Regulatory News (MCON)

Share Price Information for Mincon Grp (MCON)

Share Price is delayed by 15 minutes
Get Live Data
58.00    0.00 (0.00%)
Bid:
56.00
Ask:
60.00
Spread: 4.00 (7.143%)
Market Cap: £123.23m
MCON Live PriceLast checked at - London Stock Exchange

Intraday Mincon Grp Share Chart

Director/PDMR Shareholding

20 Mar 2026 17:00

RNS Number : 5463X
Mincon Group Plc
20 March 2026
Β 

Mincon Group plc

("Mincon" or the "Company")

Β 

Director / PDMR Shareholding

Β 

Β 

The Company announces that it has granted options over ordinary shares of nominal value €0.01 each in the capital of the Company ("Ordinary Shares") to certain employees pursuant to the Company's 2022 Long Term Incentive Plan (the "Plan").

Β 

On the 20 March 2026, options over an aggregate of 4,360,000 Ordinary Shares (the "Options") have been granted under the Plan, exercisable at a price of €0.72 each, being the share price at the time of grant. The Options will vest on the third anniversary of the award date, subject to the achievement of specified performance conditions (see below). Vested Options will expire if they have not been exercised after seven years from the date of grant.

Β 

The Options will vest subject to the satisfaction of the following performance conditions: (i) 50% of the Options will vest on the achievement by the Company of a compound annual growth rate ("CAGR") in Earnings Before Interest and Tax ("EBIT") on continuing operations greater than or equal to 22.3% over the three financial years ending on 31 December 2028; and (ii) 50% of the Options will vest on the achievement by the Company of a Return on Capital Employed ("ROCE") of greater than or equal to 12% for the financial year ended 31 December 2028.

Β 

Β 

Details of the grants of Options over Ordinary Shares to persons discharging managerial responsibilities are set out in the table at the end of this announcement.

Β 

Ends

Β 

20 March 2026

Β 

Mincon Group plc Tel: +353 (61) 361 099

Joe Purcell CEO Mark McNamara CFO

Tom Purcell COO

Β 

Davy Corporate Finance

(Nominated Adviser, Euronext Growth Listing Sponsor and Joint Broker) Tel: +353 (1) 679 6363

Anthony Farrell Daragh O'Reilly

Β 

Shore Capital (Joint Broker) Tel: +44 (0) 20 7408 4090

Malachy McEntyre Mark Percy

Daniel Bush

Β 

Β 

Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with them

Β 

This form is required for disclosure of transactions under Article 19 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (Market Abuse Regulation)

Β 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Β 

Name

Β 

Mark McNamara

2

Reason for the notification

a)

Β 

Position/status

Β 

Chief Financial Officer / PDMR

b)

Initial Notification Amendment

Β 

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Mincon Group plc

b)

LEI

635400LCBSV68KQHN886

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each

type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument,

type of instrument Identification

code

Β 

Options to subscribe for Ordinary Shares of Nominal Value €0.01 each. ISIN: IE00BD64C665

b)

Nature of the transaction

Β 

i. Grant of Options to subscribe for new Ordinary Shares under the Mincon Group plc Long Term Incentive Plan 2022. Options shall vest over a three year period, subject to the satisfaction of performance conditions.

ii. Grant of Options to subscribe for new Ordinary Shares under the Mincon Group plc Long Term Incentive Plan 2022. Options shall vest over a three year period, subject to the satisfaction of performance conditions.

Β 

c)

Price(s) and volume(s)

Price

Volume

i.

€0.72 (exercise price)

300,000

ii.

€0.42 (exercise price)

300,000

d)

Aggregated information

- Aggregated volume

- Price

Β 

N/A - Single Transaction

e)

Date of the transaction

Β 

i. 20 March 2026

ii. 8 May 2025

f)

Place of the transaction

Β 

i. Outside a trading venue

ii. Outside a trading venue

g)

Additional Information

Above transaction dated 8 May 2025 relates to PDMR disclosure in respect of wider grant of options to employees in 2025, the issue of which were previously noted in the Company's financial statements in 2025. For reference, on the 08 May 2025, options over an aggregate of 4,360,000 Ordinary Shares (the "Options") were granted under the Plan, exercisable at a price of €0.42 each, being the share price at the time of grant. The Options will vest on the third anniversary of the award date, subject to the achievement of specified performance conditions (see below). Vested Options will expire if they have not been exercised after seven years from the date of grant.

Β 

The Options will vest subject to the satisfaction of the following performance conditions: (i) 50% of the Options will vest on the achievement by the Company of a compound annual growth rate ("CAGR") in Earnings Before Interest and Tax ("EBIT") on continuing operations greater than or equal to 33.26% over the three financial years ending on 31 December 2027; and (ii) 50% of the Options will vest on the achievement by the Company of a Return on Capital Employed ("ROCE") of greater than or equal to 11.5% for the financial year ended 31 December 2027.

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHAKKBNABKDQNB
Date   Source Headline
2nd Jun 20267:00 amRNSChange in Nomad
29th May 202610:42 amRNSHolding(s) in Company
29th May 202610:16 amRNSHolding(s) in Company
29th Apr 20263:13 pmRNSResult of AGM
29th Apr 20267:00 amRNSInterim Trading Update
26th Mar 20267:00 amRNSAnnual Report and Notice of AGM
20th Mar 20265:00 pmRNSDirector/PDMR Shareholding
10th Mar 20261:36 pmRNSHolding(s) in Company
10th Mar 20267:00 amRNSFinal Results
10th Mar 20267:00 amRNSFinal Results
5th Mar 202611:30 amRNSHolding(s) in Company
29th Jan 20266:12 pmRNSHolding(s) in Company
19th Jan 20262:52 pmRNSHolding(s) in Company
23rd Oct 20257:00 amRNSQ3 2025 Trading Update
26th Sep 20259:42 amRNSDirectorate Change
5th Aug 20257:00 amRNSHalf-year Report
19th May 20257:00 amRNSBoard Changes
1st May 20254:30 pmRNSResult of AGM
1st May 20257:00 amRNSInterim Trading Update
26th Mar 202512:00 pmRNSAnnual Report and Notice of AGM
10th Mar 20257:00 amRNSFinal Results
30th Dec 20244:00 pmRNSHolding(s) in Company
29th Oct 20247:00 amRNSDividend Notice
25th Oct 20247:00 amRNSInterim Trading Update
6th Aug 20247:00 amRNSHalf Yearly Report
7th May 20247:00 amRNSInterim Trading Update
2nd May 20245:00 pmRNSResult of AGM
27th Mar 20247:00 amRNSAnnual Report and Notice of AGM
15th Mar 20247:00 amRNSDirector/PDMR Shareholding
11th Mar 20247:00 amRNSFinal Results
6th Feb 20247:00 amRNSFull Year Trading Update and Notice of Results
6th Dec 20237:00 amRNSBoard Changes
1st Dec 20237:00 amRNSDirector/PDMR Shareholding
9th Oct 20237:00 amRNSInterim Trading Update
8th Aug 20237:00 amRNSHalf Yearly Report
4th Jul 20237:00 amRNSAppointment of COO
9th May 20237:00 amRNSInterim Trading Update
4th May 20233:30 pmRNSResult of AGM
28th Mar 20237:00 amRNSAnnual Report and Notice of AGM
13th Mar 20237:00 amRNSFinal Results
1st Nov 20227:00 amRNSQ3 Trading Update
5th Sep 202211:21 amRNSGreenhammer Commercial Contract
9th Aug 202210:15 amRNSHolding(s) in Company
8th Aug 20227:00 amRNSHalf Yearly Report
9th May 20227:00 amRNSInterim Trading Update
5th May 20223:00 pmRNSResult of AGM
5th Apr 20227:00 amRNSAnnual Report and Notice of AGM
15th Mar 20227:00 amRNSHolding(s) in Company
14th Mar 20227:00 amRNSDirector Appointment
14th Mar 20227:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.